ACB Arrests DCO Handwara In Bribery Case

Kupwara: In a significant crackdown on corruption, Anti-Corruption Bureau (ACB) apprehended the Drug Control Officer (DCO) of Kupwara in the Bumhama area on Tuesday.

The arrest came in response to persistent complaints against the V.officer for soliciting and accepting bribes from a medical shop owner.

ACB officials revealed that a series of complaints prompted them to launch a meticulous operation to catch the corrupt officer. Despite evading previous traps, the DCO was caught red-handed during a carefully orchestrated operation on Tuesday.

The investigation unveiled that the officer had recently seized medicine from a medical store in the Villgam area. Instead of adhering to the prescribed procedure of taking the confiscated drugs to his office, he unlawfully left them at a medical store in Handwara.

The DCO identified as Ishtiyaq Ahmad allegedly demanded a bribe from a complainant for releasing the seized medicine, a deviation from the established norms. According to ACB officials, as mandated by regulations, the officer failed to provide the necessary receipt for the confiscated drugs.

The accused was subsequently taken to Handwara to identify the drugs left at the medical store. Reports indicate that the DCO had been extorting bribes from various medical shop owners, creating a hostile environment for them.

The news of the arrest quickly spread, earning praise from the public for the Anti-Corruption Bureau’s decisive action against employees engaging in corrupt practices.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’